Advanced Search

The Burden of Asthma Symptoms and the Positive Role of Patient Management

Contents:

Author Info

  • Edward C.Y. Wang

    (Wyeth-Ayerst Canada, Inc., North York, Ontario, Canada)

  • Kathryn A. Gaebel

    (Wyeth-Ayerst Canada, Inc., North York, Ontario, Canada)

Registered author(s):

    Abstract

    Background: Asthma is a major public health problem in developed countries. In Canada, the prevalence of asthma is approximately 5 to 7%, with some provincial variation. A retrospective study using data collected in 1990 estimated the total costs of asthma in Canada to be between $Can504 million and $Can648 million (1990 dollars). 61% of all asthma costs were direct costs ($Can306 million). Of these, drugs were the single largest component ($Can124 million). Illness-related disability ($Can76 million) was the largest contributor to indirect costs. Objective: To obtain individual patient-derived data on productivity loss and level of function related to severity of asthma symptoms, and briefly review the published data on the role of education and drug therapy in asthma management. Design: This was a community-based prospective study of outpatients identified from the bronchial inhaler study of the Canadian Pharmacy Medication Monitoring Program. Methods: Study patients recruited through community pharmacies were monitored for 6 months. Data were collected through structured telephone interviews at 1, 3 and 6 months. Primary Outcome Measures and Results: The primary outcome measures were symptom-free days (SFDs), productivity-loss days (PLDs) and patient-reported function level. Patients who did not use inhaled corticosteroids had similar numbers of SFDs and PLDs compared with patients who did. Daily corticosteroid usage was a surrogate measure for severe disease because this group also reported fewer SFDs and more PLDs than patients who use corticosteroids as needed and patients who did not use inhaled corticosteroids. Discussion: The evidence suggests that the greatest impact on productivity for the majority of patients comes from the number of days symptoms interfere with usual daily activities as opposed to actual days missed from work. Further, if corticosteroids are used appropriately in current nonusers who are not optimally controlled, a decrease in PLD and an increase in SFD may be seen. Results from another Canadian study have depicted the under-prescribing of inhaled corticosteroids, and the effectiveness of asthma education on improving the quality of life. A meta-analysis of relevant studies has confirmed that education improves important clinical outcomes in adults with asthma. Conclusions: Better patient management in asthma is needed to reduce the economic burden of this disease.

    Download Info

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
    File URL: http://diseasemanagement.adisonline.com/pt/re/dmo/pdfhandler.00115677-199906020-00004.pdf
    Download Restriction: Pay per view
    File URL: http://diseasemanagement.adisonline.com/pt/re/dmo/fulltext.00115677-199906020-00004.htm
    Download Restriction: Pay per view

    As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

    Bibliographic Info

    Article provided by Wolters Kluwer Health | Adis in its journal Disease Management & Health Outcomes.

    Volume (Year): 6 (1999)
    Issue (Month): 2 ()
    Pages: 83-91
    Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF
    Handle: RePEc:wkh:dmhout:v:6:y:1999:i:2:p:83-91

    Contact details of provider:
    Web page: http://diseasemanagement.adisonline.com/

    For corrections or technical questions regarding this item, or to correct its listing, contact: (Dave Dustin).

    Related research

    Keywords: Pharmacoeconomics; Asthma; Cost-analysis; Quality-of-life; Antiasthmatics; Patient-education;

    Find related papers by JEL classification:

    References

    No references listed on IDEAS
    You can help add them by filling out this form.

    Citations

    Lists

    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

    Statistics

    Access and download statistics

    Corrections

    When requesting a correction, please mention this item's handle: RePEc:wkh:dmhout:v:6:y:1999:i:2:p:83-91

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dave Dustin).

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.